Proteasome inhibitors: new class of antitumor agents

by Gordan Srkalović
Published 2003-11-01

Immunomodulatory Compounds (Imids®) in the Treatment of Multiple Myeloma

by Gordan Srkalovic, Mohamad Hussein
Published 2009-10-01

Relative dose intensity of systemic chemotherapy in an outpatient cancer center

by Christine Uptigrove, Kari Vavra, Claire Saadeh, Gordan Srkalovic
Published 2010-11-01

TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease

by Gordan Srkalovic, Inga Marijanovic, Maya B Srkalovic, David C Fajgenbaum
Published 2017-05-01

Prognostic factors of overall survival for patients with stage II colon cancer

by Harsha Trivedi, Ushasree Chamarthy, Luciano Dicarlo, James Herman, Gordan Srkalovic
Published 2014-11-01

MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial

by Hatem Soliman, Varsha Shah, Gordan Srkalovic, Reshma Mahtani, Ellis Levine, Blanche Mavromatis, Jayanthi Srinivasiah, Mohamad Kassar, Robert Gabordi, Rubina Qamar, Sarah Untch, Heather M. Kling, Tina Treece, William Audeh
Published 2020-01-01

Patient‐reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the...

by Laurie E. Steffen McLouth, Fengmin Zhao, Taofeek K. Owonikoko, Josephine L. Feliciano, Nisha A. Mohindra, Suzanne E. Dahlberg, James L. Wade III, Gordan Srkalovic, Bradley W. Lash, Joseph W. Leach, Ticiana A. Leal, Charu Aggarwal, David Cella, Suresh S. Ramalingam, Lynne I. Wagner
Published 2020-10-01